THIAZOLOPYRIMIDONES AS INHIBITORS OF DDR1/2 AND THERAPEUTIC USES THEREOF

The present invention relates to a group of compounds of formula (I):which are inhibitors of the Discoidin Domain Receptors (DDR1/2), whose overexpression is produced in several diseases such as cancer, pulmonary fibrosis, cirrhotic liver, liver fibrosis, lupus nephritis, osteoarthritis, rheumatoid...

Full description

Saved in:
Bibliographic Details
Main Authors PASTOR FERNÁNDEZ, Joaquín, GARCÍA CAMPOS, FRANCISCO JAVIER, BLANCO-APARICIO, Carmen, MARTÍNEZ GONZÁLEZ, Sonia
Format Patent
LanguageEnglish
French
German
Published 27.07.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a group of compounds of formula (I):which are inhibitors of the Discoidin Domain Receptors (DDR1/2), whose overexpression is produced in several diseases such as cancer, pulmonary fibrosis, cirrhotic liver, liver fibrosis, lupus nephritis, osteoarthritis, rheumatoid arthritis and atherosclerosis, so the compounds of the invention are useful for the treatment of said diseases.
Bibliography:Application Number: EP20210382044